A nuclear import inhibitory peptide ameliorates the severity of cholecystokinin-induced acute pancreatitis

doi:10.3748/wjg.v11.i7.990

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 7

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3949)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-8) series, Tables (1-3) series.

Item

Count

PDF

329

HTML

3261

Figures (1-8)

180

Tables (1-3)

179

Sum=3949

Feb 21, 2005 (publication date) through Aug 27, 2024

Times Cited of This Article

Times Cited (28)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Feb 21, 2005; 11(7): 990-999
Published online Feb 21, 2005. doi: 10.3748/wjg.v11.i7.990

Full Size Figure Download Figure

Figure 6 Effect of PN50 treatment on the pancreatic malondialdehyde (MDA) (A) and reduced glutathione (GSH) levels (B) in CCK-induced acute pancreatitis. ^bP<0.01 vs group PS; ^cP<0.05, ^dP<0.01 vs group CCK.

Citation: Letoha T, Somlai C, Takács T, Szabolcs A, Jármay K, Jr ZR, Hegyi P, Varga I, Kaszaki J, Krizbai I, Boros I, Duda E, Kusz E, Penke B. A nuclear import inhibitory peptide ameliorates the severity of cholecystokinin-induced acute pancreatitis. World J Gastroenterol 2005; 11(7): 990-999
URL: https://www.wjgnet.com/1007-9327/full/v11/i7/990.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i7.990